The potential commercialization of neuronal replacement therapy using smart polymers
Author(s)
Dutt, Anindita, 1971-
DownloadFull printable version (6.932Mb)
Other Contributors
Management of Technology Program.
Advisor
Edward B. Roberts, Robert S. Langer and Mriganka Sur.
Terms of use
Metadata
Show full item recordAbstract
NeuroBioChip Device is a programmable, biocompatible, biodegradable, polymer matrix which allows the growth and programming of donor neurons. It creates a microenvironment conducive for neuronal outgrowth and promises a novel cure for neurological disorders caused by localized sites of brain damage, such as Parkinson's disease, stroke, and spinal injury. This chip is being researched in the MIT laboratories of Drs. Robert Langer and Mriganka Sur. My thesis addresses the challenges and possible strategies in commercializing this technology. The need for this treatment was evaluated in the context of current therapies available for the treatment of relevant neurological disorders. Extensive field interviews were conducted. Among other factors, the varying clockspeeds between different components of the device, the unsustainable cost structure and the emerging status of complementary technologies suggested that the development of the therapy is best pursued in collaboration with a large biopharmaceutical or medical device firm.
Description
Thesis (S.M.M.O.T.)--Massachusetts Institute of Technology, Sloan School of Management, Management of Technology Program, 2005. Includes bibliographical references (leaves 108-122).
Date issued
2005Department
Management of Technology Program.; Sloan School of ManagementPublisher
Massachusetts Institute of Technology
Keywords
Management of Technology Program.